Adrian Newman-Tancredi, PhD, DSc, Co-founder, CEO
Dr. Newman-Tancredi has broad expertise in neuroscience drug discovery and early pre-clinical development. He was previously Director of Neurobiology and Project Manager at Pierre Fabre Laboratories. More...
Mark S. Kleven, PhD, Senior VP, Scientific Operations, COO
Dr. Kleven has wide experience in small and mid-sized pharma companies as a pharmacologist and manager of FDA, NIH and DOD-compliant dossiers. He was previously VP at Biousian Systems and Ceptaris. More...
Steven A. Johnson, PhD, Vice-President, Drug Development
Dr. Johnson has extensive experience of pre-clinical and clinical drug development in neurobiology and neuropsychiatry. He was previously Vice-President and Executive Officer at Cortex Pharmaceuticals. More...
Christopher Jankosky, MD, MPH, Chief Medical Officer
Dr. Jankosky, USA, is board certified in both neurology and occupational and environmental medicine. He has high level experience in FDA and as a Navy Captain where he held executive positions. He maintains adjunct faculty appointments at the University of Maryland and the Uniformed Services University. More...
Fabienne Herbrecht, PhD, Director, Clinical Development
Dr Herbrecht has over 25 years of experience in the Human and Veterinary Pharmaceutical Industry, working in three main areas: clinical development, quality assurance and regulatory affairs. More...
Ronan Depoortere, PhD, Director, Pharmacology
Dr. Depoortere is a highly experienced pharmacologist and participated in the characterization of antipsychotics and antidepressants. He was previously Senior Scientist at Sanofi and Synthelabo. More...
Violette Richin, DPharm, Researcher in Radioimaging
Violette Richin is Doctor of Pharmacy and graduated from the University of Lyon. She completed her training with a Master degree in Medicinal Chemistry and Molecular Pharmacology at the University of Paris. More...
